维普中文期刊产品整合服务
15篇 您的检索式:作者名="Noriyo"
    题名 作者 年代 出处 被引量
1Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study显示文摘Miwa Kawanaka Mitsuhiko Suehiro Gotaro Yamada Jun Nakamura Keisuke Hino Ken Nishino Junji Yodoi Hajime Nakamura Hirofumi Kawamoto Takahito Oka Noriyo Urata Daisuke Goto 20132013 (defa)2013,,:2
2Noninvasive Estimation of Hepatic Steatosis in Living Liver Donors: Usefulness of Visceral Fat Area Measurement显示文摘Noriyo Yamashiki Yasuhiko Sugawara Sumihito Tamura Junichi Kaneko Yuichi Matsui Junichi Togashi Takamasa Ohki Haruhiko Yoshida Masao Omata Masatoshi Makuuchi Norihiro Kokudo 2009Transplantation2009,,4:1
3Imaging Diagnosis of Interstitial Pneumonia with Emphysema (Combined Pulmonary Fibrosis and Emphysema)显示文摘Fumikazu Sakai Junya Tominaga Akiko Kaga Yutaka Usui Minoru Kanazawa Takashi Ogura Noriyo Yanagawa Tamiko Takemura Masahito Ebina 2012Pulmonary Medicine2012,,:1
4The Distribution of Inflammation and Virus in Human Enterovirus 71 Encephalomyelitis Suggests Possible Viral Spread by Neural Pathways显示文摘Kum Thong Wong Badmanathan Munisamy Kien Chai Ong Hideaki Kojima Nagata Noriyo Kaw Bing Chua Beng Beng Ong Kazuo Nagashima 2008Journal of Neuropathology and Experimental Neurology2008,,2:1
5Spectral imaging fluorescence microscopy显示文摘TOKUKO H TAKESHI S NORIYO H 2002Genes to Cells2002,7,:1
6Postoperative surveillance with monthly serum tumor markers after living‐donor liver transplantation for hepatocellular carcinoma显示文摘Noriyo Yamashiki Yasuhiko Sugawara Sumihito Tamura Ryosuke Tateishi Haruhiko Yoshida Junichi Kaneko Yuichi Matsui Junichi Togashi Masaaki Akahane Masatoshi Makuuchi Masao Omata Norihiro Kokudo 2010Hepatology Research2010,,3:1
7Analysis of Magnetizing Process Using Discharge Current of Capacitor by 3-D Finite-Element Method显示文摘 Tadashi Yamaguchi Noriyo Mimura 2002IEEE Transactions on Magnetica2002,38,2:1
8The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways显示文摘Wong K T Munisamy B Ong K C Kojima H Noriyo N Chua K B 2008J Neuropathol Exp Neurol2008,67,:1
9Analysis of magnetizing process using discharge current of capacitor by 3-D finite-element method显示文摘Yoshihiro K Tadashi Y Noriyo M 2002IEEE Transactions on Magnetics2002,38,2:1
10Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus显示文摘Lan-Jun Liu Takako Suzuki Hiroshi Tsunemitsu Michiyo Kataoka Noriyo Ngata Naokazu Takeda Takaji Wakita Tatsuo Miyamura Tian-Cheng Li 2008Archives of Virology2008,,12:1
11Differential localization of ner- vous susceptible to enterovirus 71 and poliovirus type 1 in the cen- tral nervous system of cynomolgus monkeys after intravenous inocu- lation显示文摘Noriyo N Takuya I Yasushi A 2004J Gen Virol2004,85,:1
12An attenuated strain of entero- virus 71 belonging to genotype a showed a broad spectrum of antige-nicity with attenuated neurovirulence in cynomolgus monkeys显示文摘Minetaro A Noriyo N Naoko I 2007J Virol2007,81,:1
13Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening显示文摘Noriyo Tanaka Yoshinao Muro Kazumitsu Sugiura Yasushi Tomita 2008Modern Rheumatology2008,,6:1
14Recurrence of cholestatic liver disease after living donor liver transplantation显示文摘End-stage liver disease, due to cholestatic liver diseases with an autoimmune background such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC), is considered a good indication for liver transplantation. Excellent overall patient and graft outcomes, based mostly on the experience from deceased donor liver transplantation (DDLT), have been reported. Due to the limited number of organ donations from deceased donors in most Asian countries, living donor liver transplantation (LDLT) is the mainstream treatment for end-stage liver disease, including that resulting from PBC and PSC. Although the initial experiences with LDLT for PBC and PSC seem satisfactory or comparable to that with DDLT, some aspects, including the timing of transplantation, the risk of recurrent disease, and its long-term clinical implications, require further evaluation. Whether or not the long-term outcomes of LDLT from a biologically related donor are equivalent to that of DDLT requiresfurther observations. The clinical course following LDLT may be affected by the genetic background shared between the recipient and the living related donor.Sumihito Tamura Yasuhiko Sugawara Junichi Kaneko Junichi Togashi Yuichi Matsui Noriyo Yamashiki Norihiro Kokudo Masatoshi Makuuchi 2008World Journal of Gastroenterology2008,14,33:0
15Combination of type Ⅳ collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease显示文摘BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is the most common cause of chronic liver disease and affects approximately 25%of the general global adult population.The prognosis of NAFLD patients with advanced liver fibrosis is known to be poor.It is difficult to assess disease progression in all patients with NAFLD;thus,it is necessary to identify patients who will show poor prognosis.AIM To investigate the efficacy of non-invasive biomarkers for predicting disease progression in patients with NAFLD.METHODS We investigated biomarkers associated with mortality in patients with NAFLD who visited the Kawasaki Medical School General Medical Center from 1996 to 2018 and underwent liver biopsy and had been followed-up for>1 year.Cumulative overall mortality and liver-related events during follow-up were calculated using the Kaplan-Meier analysis and compared using log-rank testing.We calculated the odds ratio and performed receiver operating characteristic curve analysis with logistic regression analysis to determine the optimal cut-off value with the highest prognostic ability.RESULTS We enrolled 489 patients who were followed-up for a period of 1-22.2 years.In total,13 patients died(2.7%of total patients enrolled);7 patients died due to liverrelated causes.Poor prognosis was associated with liver fibrosis on histological examination but not with inflammation or steatosis.Blood biomarkers associated with mortality were platelet counts,albumin levels,and type IV collagen 7S levels.The optimal cutoff index for predicting total mortality was a platelet count of 15×10^(4)/μL,albumin level of 3.5 g/dL,and type IV collagen 7S level of 5 mg/dL.In particular,only one-factor patients with NAFLD presenting with platelet counts≤15×10^(4)/μL,albumin levels≤3.5 g/dL,or type IV collagen 7S≥5 mg/dL showed 5-year,10-year,and 15-year survival rates of 99.7%,98.3%,and 94%,respectively.However,patients with two factors had lower 5-year and 10-year survival rates of 98%and 43%,respectively.Similarly,patients with all three factors showed the lowest 5-year and 10-year survival rates of 53%and 26%,respectively.CONCLUSION A combination of the three non-invasive biomarkers is a useful predictor of NAFLD prognosis and can help identify patients with NAFLD who are at a high risk of all-cause mortality.Miwa Kawanaka Ken Nishino Katsunori Ishii Tomohiro Tanikawa Noriyo Urata Mitsuhiko Suehiro Takako Sasai Ken Haruma Hirofumi Kawamoto 2021World Journal of Hepatology2021,13,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费